Region:Asia
Author(s):Shubham
Product Code:KRAB5653
Pages:83
Published On:October 2025

By Type:The market is segmented into various types of medical devices, including diagnostic devices, therapeutic devices, monitoring devices, surgical instruments, connected health devices, imaging equipment, and others. Each sub-segment plays a crucial role in addressing specific healthcare needs and improving patient outcomes.

The diagnostic devices segment is currently dominating the market due to the increasing demand for early disease detection and monitoring. Innovations in imaging technologies and point-of-care testing have significantly enhanced diagnostic capabilities, leading to better patient management. The rise in chronic diseases and the need for regular health check-ups have further propelled the growth of this segment, making it a critical component of the healthcare system.
By End-User:The market is segmented by end-users, including hospitals, clinics, home healthcare, rehabilitation centers, research institutions, and others. Each end-user category has distinct requirements and contributes to the overall demand for medical devices and connected health solutions.

Hospitals are the leading end-user segment, accounting for a significant share of the market. This dominance is attributed to the high volume of medical procedures performed in hospitals, which require advanced medical devices and technologies. The increasing number of hospitals and the expansion of healthcare facilities in urban areas further drive the demand for medical devices, making hospitals a key player in the market.
The South Korea Medical Devices and Connected Health Market is characterized by a dynamic mix of regional and international players. Leading participants such as Samsung Medison Co., Ltd., LG Electronics Inc., Medtronic Korea Ltd., Siemens Healthineers, GE Healthcare Korea, Philips Korea Ltd., Johnson & Johnson Medical Korea, Stryker Korea Ltd., Boston Scientific Korea, Abbott Laboratories Korea, B. Braun Korea Ltd., Terumo Corporation, Olympus Corporation, Roche Diagnostics Korea, Hologic, Inc. contribute to innovation, geographic expansion, and service delivery in this space.
The South Korean medical devices and connected health market is poised for significant transformation, driven by technological advancements and demographic shifts. As the population ages, the demand for innovative healthcare solutions will continue to rise, prompting increased investment in telehealth and AI integration. Furthermore, collaborations between healthcare providers and technology firms are expected to enhance service delivery and patient engagement. These trends indicate a robust future for the market, characterized by a focus on personalized and preventive healthcare solutions.
| Segment | Sub-Segments |
|---|---|
| By Type | Diagnostic Devices Therapeutic Devices Monitoring Devices Surgical Instruments Connected Health Devices Imaging Equipment Others |
| By End-User | Hospitals Clinics Home Healthcare Rehabilitation Centers Research Institutions Others |
| By Application | Cardiovascular Orthopedics Neurology Diabetes Management Respiratory Care Others |
| By Distribution Channel | Direct Sales Distributors Online Sales Retail Pharmacies Others |
| By Region | Seoul Busan Incheon Daegu Gwangju Others |
| By Price Range | Low-End Devices Mid-Range Devices High-End Devices |
| By Technology | Digital Health Technologies Mobile Health Applications Remote Patient Monitoring Telemedicine Solutions Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Medical Device Manufacturers | 100 | Product Managers, R&D Directors |
| Healthcare Providers | 80 | Hospital Administrators, Clinical Directors |
| Regulatory Bodies | 50 | Regulatory Affairs Specialists, Compliance Officers |
| Connected Health Technology Firms | 70 | Technology Developers, Business Development Managers |
| Healthcare Consultants | 60 | Market Analysts, Strategy Consultants |
The South Korea Medical Devices and Connected Health Market is valued at approximately USD 12.5 billion, reflecting significant growth driven by an aging population, chronic disease prevalence, and technological advancements in healthcare.